<?xml version='1.0' encoding='utf-8'?>
<!DOCTYPE article PUBLIC "-//NLM//DTD JATS (Z39.96) Journal Publishing DTD v1.2 20190208//EN" "http://jats.nlm.nih.gov/publishing/1.2/JATS-journalpublishing1.dtd">
<article article-type="research-article" dtd-version="1.2" xml:lang="ru" xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink"><front><journal-meta><journal-id journal-id-type="issn">2658-6533</journal-id><journal-title-group><journal-title>Research Results in Biomedicine</journal-title></journal-title-group><issn pub-type="epub">2658-6533</issn></journal-meta><article-meta><article-id pub-id-type="doi">10.18413/2658-6533-2019-5-4-0-7</article-id><article-id pub-id-type="publisher-id">1839</article-id><article-categories><subj-group subj-group-type="heading"><subject>Pharmacology</subject></subj-group></article-categories><title-group><article-title>Feasibility study of the eye drops composition with vitamins for the treatment of allergic conjunctivitis</article-title><trans-title-group xml:lang="en"><trans-title>Feasibility study of the eye drops composition with vitamins for the treatment of allergic conjunctivitis</trans-title></trans-title-group></title-group><contrib-group><contrib contrib-type="author"><name-alternatives><name xml:lang="ru"><surname>Tsurkan</surname><given-names>Maria V.</given-names></name><name xml:lang="en"><surname>Tsurkan</surname><given-names>Maria V.</given-names></name></name-alternatives><email>ts.mary@rambler.ru</email></contrib><contrib contrib-type="author"><name-alternatives><name xml:lang="ru"><surname>Zhilyakova</surname><given-names>Elena T.</given-names></name><name xml:lang="en"><surname>Zhilyakova</surname><given-names>Elena T.</given-names></name></name-alternatives><email>ezhilyakova@bsu.edu.ru</email></contrib><contrib contrib-type="author"><name-alternatives><name xml:lang="ru"><surname>Timoshenko</surname><given-names>Elena Yu.</given-names></name><name xml:lang="en"><surname>Timoshenko</surname><given-names>Elena Yu.</given-names></name></name-alternatives><email>timoshenko@bsu.edu.ru</email></contrib><contrib contrib-type="author"><name-alternatives><name xml:lang="ru"><surname>Martseva</surname><given-names>Diana S.</given-names></name><name xml:lang="en"><surname>Martseva</surname><given-names>Diana S.</given-names></name></name-alternatives><email>martseva@bsu.edu.ru</email></contrib><contrib contrib-type="author"><name-alternatives><name xml:lang="ru"><surname>Naplekov</surname><given-names>Denis K.</given-names></name><name xml:lang="en"><surname>Naplekov</surname><given-names>Denis K.</given-names></name></name-alternatives><email>783767@bsu.edu.ru</email></contrib><contrib contrib-type="author"><name-alternatives><name xml:lang="ru"><surname>Ivanova</surname><given-names>Veronika E.</given-names></name><name xml:lang="en"><surname>Ivanova</surname><given-names>Veronika E.</given-names></name></name-alternatives><email>ivanova_v@bsu.edu.ru</email></contrib></contrib-group><pub-date pub-type="epub"><year>2019</year></pub-date><volume>5</volume><issue>4</issue><fpage>0</fpage><lpage>0</lpage><self-uri content-type="pdf" xlink:href="/media/medicine/2019/4/Биомедицинские_исслеования_4_219-94-102.pdf" /><abstract xml:lang="ru"><p>Background: Today, quite a lot of people suffer from allergic conjunctivitis, despite the sufficient market of monocomponent medicines, there is a shortage of combined medicines based on modern substances on the market. The aim of the study: Theoretical justification of the possibility of using water-soluble B vitamins, ascorbic acid, and rutin as substances in combined ophthalmic solutions for allergic conjunctivitis. Materials and methods: Since the inflammatory reaction of the conjunctiva is at the heart of the allergic conjunctivitis, in order to improve the course of the disease, it is rational to introduce into the composition of a combined medicament for its treatment a component that can affect the development of inflammation by another mechanism of action which is different from the mechanism of action of the main active substance. The authors considered soluble and insoluble vitamins with anti-inflammatory properties &amp;ndash; ascorbic acid, rutin, thiamine, riboflavin, nicotinic acid, pyridoxine and cyanocobalamin &amp;ndash; as research objects for possible introduction of an additional anti-inflammatory agent in the eye drops for the treatment of allergic conjunctivitis. In the literature review, the authors considered in detail the solubility of these vitamins in water, their stability, and the presence of additional properties that could affect the eye in general. Results: In the end of the study, it was found that the introduction of vitamins B2, B3, B12, P into the eye drops on the water base requires the use of various techniques that increase their solubility, because they have poor solubility in water, and, conversely, the introduction of vitamins C, В1, В6 is possible without the use of any additional technological methods. Conclusion: Riboflavin, nicotinic acid and cyanocobalamin can be used as an additional anti-inflammatory component in the composition of eye drops on a water basis for the treatment of allergic conjunctivitis.</p></abstract><trans-abstract xml:lang="en"><p>Background: Today, quite a lot of people suffer from allergic conjunctivitis, despite the sufficient market of monocomponent medicines, there is a shortage of combined medicines based on modern substances on the market. The aim of the study: Theoretical justification of the possibility of using water-soluble B vitamins, ascorbic acid, and rutin as substances in combined ophthalmic solutions for allergic conjunctivitis. Materials and methods: Since the inflammatory reaction of the conjunctiva is at the heart of the allergic conjunctivitis, in order to improve the course of the disease, it is rational to introduce into the composition of a combined medicament for its treatment a component that can affect the development of inflammation by another mechanism of action which is different from the mechanism of action of the main active substance. The authors considered soluble and insoluble vitamins with anti-inflammatory properties &amp;ndash; ascorbic acid, rutin, thiamine, riboflavin, nicotinic acid, pyridoxine and cyanocobalamin &amp;ndash; as research objects for possible introduction of an additional anti-inflammatory agent in the eye drops for the treatment of allergic conjunctivitis. In the literature review, the authors considered in detail the solubility of these vitamins in water, their stability, and the presence of additional properties that could affect the eye in general. Results: In the end of the study, it was found that the introduction of vitamins B2, B3, B12, P into the eye drops on the water base requires the use of various techniques that increase their solubility, because they have poor solubility in water, and, conversely, the introduction of vitamins C, В1, В6 is possible without the use of any additional technological methods. Conclusion: Riboflavin, nicotinic acid and cyanocobalamin can be used as an additional anti-inflammatory component in the composition of eye drops on a water basis for the treatment of allergic conjunctivitis.</p></trans-abstract><kwd-group xml:lang="ru"><kwd>allergic conjunctivitis</kwd><kwd>vitamins</kwd><kwd>anti-inflammatory vitamins</kwd></kwd-group><kwd-group xml:lang="en"><kwd>allergic conjunctivitis</kwd><kwd>vitamins</kwd><kwd>anti-inflammatory vitamins</kwd></kwd-group></article-meta></front><back><ref-list><title>Список литературы</title><ref id="B1"><mixed-citation>Mishra GP, Tamboli V, Jwala J, Mitra AK. Recent Patents and Emerging Therapeutics in the Treatment of Allergic Conjunctivitis. 2011;: https://doi.org/10.2174/187221311794474883</mixed-citation></ref><ref id="B2"><mixed-citation>Medunitsyna EN. [Complex therapy of allergic manifestations in the period of exacerbation]. Meditsinskii sovet. 2015;7:59-63. Russian.</mixed-citation></ref><ref id="B3"><mixed-citation>Smirnova SV, Taptygina EV, Bronnikova EP. [Allergy and pseudo-allergy: ecologic aspects of geographic pathology]. Ekologiia cheloveka. 2017;7:3-10. Russian.</mixed-citation></ref><ref id="B4"><mixed-citation>Khalimov AR. [Riboflavin film in UV corneal cross-linking. ex vivo study]. Meditsinskii vestnik Bashkorkostana. 2017;12(1(67)):65-65. Russian.</mixed-citation></ref><ref id="B5"><mixed-citation>Koplin JJ, Allen KJ, Gurrin LC, et al. The Impact of Family History of Allergy on Risk of Food Allergy: A Population-Based Study of Infants. International Journal of Environmental Research and Public Health. 2011;10:5364-5377. DOI: https://doi.org/10.3390/ijerph10115364</mixed-citation></ref><ref id="B6"><mixed-citation>Yang H, Lee S, Suh DI, et al. The Cohort for Childhood Origin of Asthma and allergic diseases (COCOA) study: design, rationale and methods. BMC Pulmonary Medicine. 2014;109:14. DOI: https://doi.org/10.1186/1471-2466-14-109</mixed-citation></ref><ref id="B7"><mixed-citation>Hong J, Zhong T, Li H, et al. Ambient air pollution, weather changes, and outpatient visits for allergic conjunctivitis: A retrospective registry study. Scientific Reports [Internet]. 2016 [cited 2018 March 27];6. Available from: https://www.nature.com/articles/srep23858.</mixed-citation></ref><ref id="B8"><mixed-citation>Lee H, Kim EK, Kim HY, et al. PLoS One. 2017;https://doi.org/10.1371/journal.pone.0173328.</mixed-citation></ref><ref id="B9"><mixed-citation>Tsurkan MV, Martseva DS. [Marketing analysis of medicines for the treatment of allergic conjunctivitis]. Natsionalnyi farmatsevtychnyi universytet. 2017;3:348-350. Russian</mixed-citation></ref><ref id="B10"><mixed-citation>Ackerman St, Smith LM, Gomes PJ. Ocular itch associated with allergic conjunctivitis: latest evidence and clinical management. Therapeutic Advanced in Chronic Disease. 2016;7(1):52-67. DOI: https://doi.org/10.1177/2040622315612745</mixed-citation></ref><ref id="B11"><mixed-citation>Cingu AK, Cinar Ya, Turkcu FM, et al. Effects of vernal and allergic conjunctivitis on severity of keratoconus. International Journal of Ophthalmology. 2013;6(3):370-374. DOI: 10.3980/j.issn.2222-3959.2013.03.21</mixed-citation></ref><ref id="B12"><mixed-citation>Narzikulova KI, Kodirova ShR, Abdullaeva GD. [Comparative assessment of efficiency of pallada preparation in the treatment of allergic conjunctivitis]. Vestnik soveta molodykh uchenykh i spetsialistov Cheliabinskoi oblasti. 2016;4(3(14)):67-69. Russian.</mixed-citation></ref><ref id="B13"><mixed-citation>Reyes NJ, Mayhew E, Chen PW, et al. &amp;gamma;&amp;delta; T Cells Are Required for Maximal Expression of Allergic Conjunctivitis. Investigative opthalmology &amp;amp; visualscience. 2011;52(5):2211-2216.</mixed-citation></ref><ref id="B14"><mixed-citation>Wei Ch-Ch, Kung Yung-J, Sheng ChCh, et al. Allergic Conjunctivitis-induced Retinal Inflammation Promotes Myopia Progression. EbioMedicine. 2018;28:274-286. DOI: https://doi.org/10.1016/j.ebiom.2018.01.024</mixed-citation></ref><ref id="B15"><mixed-citation>Tsurkan MV, Zhilyakova ET. [Rationale for the development of the composition of the ophthalmic medicament for the treatment of allergic conjunctivitis]. Natsionalnyi farmatsevtychnyi universytet. 2017;2:218-222. Russian.</mixed-citation></ref><ref id="B16"><mixed-citation>Strokov IA, Drokonova OO, Akhmedzhanova LT. [Combination therapy of back pain with B vitamins and non-steroidal anti-inflammatory drugs]. Meditsinskii sovet. 2013;12:34-37. Russian.</mixed-citation></ref><ref id="B17"><mixed-citation>Ponce-Monter HA, Ortiz MI, Garza-Hernandez AF, et al. Effect of Diclofenac with B Vitamins on the Treatment of Acute Pain Originated by Lower-Limb Fracture and Surgery. Pain Res Treatment [Internet]. 2012 [cited 2018 March 27]. Available from: https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3206375.</mixed-citation></ref><ref id="B18"><mixed-citation>&amp;nbsp;Bremener SM. [Vitamins and their clinical application]. Moscow: Meditsina; 1966. Russian.</mixed-citation></ref><ref id="B19"><mixed-citation>Temerdashev ZA, Frolova NA, Tsiupko TG, et al. [Estimation of the stability of phenolic compounds and flavonoids in herbs during storage]. Khimiia rastitelnogo syrya. 2011;4:193-198. Russian.</mixed-citation></ref><ref id="B20"><mixed-citation>Dey S, Bishayi B. Riboflavin along with antibiotics balances reactive oxygen species and inflammatory cytokines and controls Staphylococcus aureus infection by boosting murine macrophage function and regulates inflammation. Journal of Inflamation. 2016;36:13. DOI: https://doi.org/10.1186/s12950-016-0145-0</mixed-citation></ref><ref id="B21"><mixed-citation>Bikbov MM, Khalimov AR, Bikbova GM, et al. [Dynamics of the riboflavin content in the moisture of the anterior chamber of the rabbit eye with transepithelial saturation of the cornea]. Meditsinskii vestnik Bashkorkostana. 2013;8(4):58-61. Russian.</mixed-citation></ref><ref id="B22"><mixed-citation>Kennedy DO. B Vitamins and the Brain: Mechanisms, Dose and Efficacy &amp;ndash; A Review. Nutriens. 2016;8(2):68-97. DOI: https://doi.org/10.3390/nu8020068</mixed-citation></ref><ref id="B23"><mixed-citation>Si Y, Zhang Y, Zhao J, et al. Niacin Inhibits Vascular Inflammation via Downregulating Nuclear Transcription Factor-&amp;kappa;B Signaling Pathway. Hindawi Publishing Corporation: Mediators of Inflammation [Internet]. 2014 [cited 2018 March 27]; Article ID 263786. Available from: https://www.hindawi.com/journals/mi/2014/263786/abs/. DOI: 10.1155/2014/263786</mixed-citation></ref><ref id="B24"><mixed-citation>Hosseinzadeh H, MoallemSA, Moshiri M, Sarnavazi MS, Etemad L. Anti-nociceptive and Anti-inflammatory Effects of Cyanocobalamin (Vitamin B12) Against Acute and Chronic Pain and Inflammation in Mice. Arzneimittelforschung. 2012;62(07):324-329. DOI: 10.1055/s-0032-1311635</mixed-citation></ref><ref id="B25"><mixed-citation>Yamashiki M, Nishimura A, Kosaka Y. Effects of methylcobalamin (vitamin B12) on vitro cytokine production of peripheral blood mononuclear cells. J Clin Lab Immunol. 1992;37(4):173-182.</mixed-citation></ref><ref id="B26"><mixed-citation>Bykovchenko I. [Vitamin problem and its solution]. Remedium. 2013;10:42-45. Russian.</mixed-citation></ref><ref id="B27"><mixed-citation>Kovalskiy IV, Krasnyuk II, Krasnyuk II (j), et al. [A study of the solubility of rutin from solid dispersions]. Khimiko-Farmatsevticheskii Zhurnal. 2013;47(11):42-45. Russian.</mixed-citation></ref><ref id="B28"><mixed-citation>Zaichenko AV, Lytkin DV, Kovalenko ingredients and excipients contained in Milgamma&amp;Ograve;Ampules]. Mezhdunarodnyi nevrologicheskii zhurnal. 2015;1(71):106-109. Russian.</mixed-citation></ref><ref id="B29"><mixed-citation>F, Zakeri-Milan P, Valizadeh H. Effects of Formulation Variables and Storage Conditions on Light Protected Vitamin B12&amp;nbsp;Mixed Parenteral Formulations. Advanced Pharmaceutical Bulletin. 2014;4(4):329-338. DOI: 10.5681/apb.2014.048</mixed-citation></ref><ref id="B30"><mixed-citation>Shnaydman LO. [Production of vitamins]. Moscow: Pishchevaya promyshlennost; 1973. Russian.</mixed-citation></ref><ref id="B31"><mixed-citation>Ribeiro DO, Pinto DC, Mauricio L, et al. Chemical stability study of vitamins thiamine, riboflavin, pyridoxine and ascorbic acid in parenteral nutrition for neonatal use. Nutrition Journal. 2011;10:47-55. DOI: https://doi.org/10.1186/1475-2891-10-47</mixed-citation></ref></ref-list></back></article>